Leap Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Cypherpunk Technologies

15/05/2023 14:32

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 10 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 32 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Leap Therapeutics Inc shares had risen by 32.4% this
quarter and
held steady so far this year.
    * The company reported a quarterly loss of $41.86 million.
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.10          -0.32          Missed
 Dec. 31 2022      -0.11          -0.10          Beat
 Sep. 30 2022      -0.12          -0.13          Missed
 Jun. 30 2022      -0.10          -0.15          Missed